DekaBank Deutsche Girozentrale decreased its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 1.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,628,489 shares of the industrial products company's stock after selling 27,880 shares during the quarter. DekaBank Deutsche Girozentrale owned about 0.67% of Xylem worth $192,278,000 at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. Dempze Nancy E raised its stake in Xylem by 0.3% during the 4th quarter. Dempze Nancy E now owns 25,761 shares of the industrial products company's stock valued at $2,989,000 after purchasing an additional 88 shares during the period. Townsquare Capital LLC boosted its stake in Xylem by 0.8% during the fourth quarter. Townsquare Capital LLC now owns 11,074 shares of the industrial products company's stock worth $1,285,000 after buying an additional 88 shares during the period. Center for Financial Planning Inc. grew its holdings in Xylem by 52.0% during the 1st quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock valued at $32,000 after purchasing an additional 91 shares during the last quarter. Keel Point LLC grew its stake in shares of Xylem by 4.1% during the fourth quarter. Keel Point LLC now owns 2,371 shares of the industrial products company's stock valued at $275,000 after buying an additional 93 shares during the last quarter. Finally, SageView Advisory Group LLC increased its stake in Xylem by 3.6% in the fourth quarter. SageView Advisory Group LLC now owns 2,790 shares of the industrial products company's stock worth $324,000 after purchasing an additional 98 shares during the period. 87.96% of the stock is owned by hedge funds and other institutional investors.
Xylem Price Performance
XYL stock traded up $0.24 on Wednesday, reaching $131.65. 892,411 shares of the company's stock were exchanged, compared to its average volume of 1,416,483. The stock has a fifty day moving average of $126.64 and a 200-day moving average of $122.37. The company has a quick ratio of 1.41, a current ratio of 1.89 and a debt-to-equity ratio of 0.18. The firm has a market cap of $32.04 billion, a PE ratio of 35.39, a P/E/G ratio of 2.39 and a beta of 1.12. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $143.50.
Xylem (NYSE:XYL - Get Free Report) last announced its earnings results on Tuesday, April 29th. The industrial products company reported $1.03 EPS for the quarter, beating analysts' consensus estimates of $0.95 by $0.08. Xylem had a return on equity of 10.12% and a net margin of 10.54%. The firm had revenue of $2.07 billion for the quarter, compared to analysts' expectations of $2.04 billion. During the same quarter in the prior year, the firm earned $0.90 EPS. Xylem's quarterly revenue was up 1.8% on a year-over-year basis. As a group, equities analysts predict that Xylem Inc. will post 4.65 EPS for the current fiscal year.
Xylem Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, June 26th. Stockholders of record on Thursday, May 29th were paid a $0.40 dividend. The ex-dividend date of this dividend was Thursday, May 29th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.22%. Xylem's dividend payout ratio (DPR) is currently 43.01%.
Analyst Upgrades and Downgrades
A number of research firms have commented on XYL. Robert W. Baird cut their target price on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 30th. Citigroup dropped their price target on Xylem from $152.00 to $134.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Stifel Nicolaus raised their target price on Xylem from $140.00 to $141.00 and gave the stock a "buy" rating in a research note on Wednesday, April 30th. Raymond James Financial upgraded shares of Xylem to a "hold" rating in a research note on Thursday, May 15th. Finally, Royal Bank Of Canada raised their target price on Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a report on Wednesday, April 30th. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $143.71.
Get Our Latest Report on Xylem
About Xylem
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
See Also

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.